← Back to guidelines
Cardiology119 papers

Cerebral malaria

Last edited: 4/14/2026

Overview

Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection, characterized by coma and seizures, often leading to multiorgan dysfunction syndrome (MODS) and high mortality rates, particularly in pediatric populations 14.

Diagnosis

  • Clinical Presentation: Coma, seizures, altered sensorium 12.
  • Laboratory Tests: Peripheral blood smear confirming P. falciparum parasitemia 1.
  • Imaging:
  • - CT brain may be normal initially; MRI can reveal deep gray and white matter involvement, diffusion restriction, and hemorrhagic transformation 2.
  • Organ Dysfunction Scoring: Use of PELOD-2, pSOFA, SICK, and LODS scores to assess MODS 45.
  • Management

  • First-Line Treatment: Intravenous antimalarial therapy, typically artesunate 1.
  • Supportive Care:
  • - Management of seizures with anticonvulsants 1. - Fluid and electrolyte balance, mechanical ventilation if respiratory failure occurs 14. - Monitoring and support for cardiac, renal, and hepatic functions 14.
  • Adjunctive Therapies: No specific adjunctive therapy demonstrated survival benefit in clinical trials 1.
  • Special Populations

  • Pediatrics: High mortality rates, frequent MODS involving multiple organs (neurologic, hematologic, renal, hepatic) 145.
  • Comorbidities: Presence of conditions like hypertension and hypothyroidism may complicate presentation and prognosis 2.
  • Key Recommendations

  • Assess and Monitor MODS: Utilize scoring systems like PELOD-2 and pSOFA to evaluate and manage multiple organ dysfunction in pediatric CM patients (Evidence: Moderate) 45.
  • Early Antimalarial Therapy: Initiate intravenous artesunate promptly for treatment of CM (Evidence: Strong) 1.
  • Supportive Care Focus: Prioritize supportive measures addressing neurologic, respiratory, cardiac, and renal dysfunctions (Evidence: Moderate) 14.
  • Consider Advanced Imaging: In cases where CT findings are inconclusive, MRI can provide critical insights into disease severity and prognosis (Evidence: Moderate) 2.
  • References

    1 Wynkoop HJ, Bvalani-Kaunda R, Seydel KB, Moxon CA, Chimalizeni Y, Taylor TE et al.. Cause-specific mortality in a cohort of paediatric cerebral malaria patients. Malaria journal 2025. link 2 Nayak B, Mohanty S, Das S, Panda S, Mishra SB. Radiological findings in fulminant cerebral malaria: a rare neuroimaging presentation. Malaria journal 2025. link 3 Nguyen B, Marshall JL, Rana C, Atem FD, Stutzman SE, Olson DM et al.. Prospective study examining the impact of cerebral angiography on quantitative pupillometer values in the interventional radiology suite. BMJ open 2024. link 4 Wynkoop HJ, Bevan A, Galeano X, Raees M, Haque MR, Taylor T et al.. Multiple Organ Dysfunction Syndrome in Malawian Children with Cerebral Malaria. The American journal of tropical medicine and hygiene 2024. link 5 Johnson H, Raees M, Urbina E, Muszynski J, Seydel K, Taylor T et al.. Multiple Organ Dysfunction Syndrome and Pediatric Logistic Organ Dysfunction-2 Score in Pediatric Cerebral Malaria. The American journal of tropical medicine and hygiene 2022. link

    Original source

    1. [1]
      Cause-specific mortality in a cohort of paediatric cerebral malaria patients.Wynkoop HJ, Bvalani-Kaunda R, Seydel KB, Moxon CA, Chimalizeni Y, Taylor TE et al. Malaria journal (2025)
    2. [2]
      Radiological findings in fulminant cerebral malaria: a rare neuroimaging presentation.Nayak B, Mohanty S, Das S, Panda S, Mishra SB Malaria journal (2025)
    3. [3]
    4. [4]
      Multiple Organ Dysfunction Syndrome in Malawian Children with Cerebral Malaria.Wynkoop HJ, Bevan A, Galeano X, Raees M, Haque MR, Taylor T et al. The American journal of tropical medicine and hygiene (2024)
    5. [5]
      Multiple Organ Dysfunction Syndrome and Pediatric Logistic Organ Dysfunction-2 Score in Pediatric Cerebral Malaria.Johnson H, Raees M, Urbina E, Muszynski J, Seydel K, Taylor T et al. The American journal of tropical medicine and hygiene (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG